Arena Pharmaceuticals Inc

Market cap: $

Exchange: NAS

Sector: Health Technology

Share
Tweet

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.

Key Statistics

Company Name

Arena Pharmaceuticals Inc

Average Volume (10 days)

0

Average Volume (30 days)

0

Moving Average (50 days)

$0

Moving Average (200 days)

$0

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

0

Shares Outstanding

61,659,385

52-Week High Split Adjust Only

0

52-Week Low Split Adjust Only

0

Employee Count

0

Beta

0

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0%

Past 30 days

0%

Past 3 months

0%

Past 6 months

0%

Past year

0%

Past 2 years

0%

Past 5 years

0%

Max % Change

0%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Arena Pharmaceuticals IncARNA65072.723.42-7.465072.7246752.73
Peer AvgN/A0.701.6411.20.700.90
Glaxosmithkline plc - ADRGSK2.104.91n/a2.102.71
Array Technologies IncARRYn/an/a37.6n/an/a
Athersys IncATHXn/an/a-4.1n/an/a